Abstract

EE248 Evolution in Price Levels of Orphan Medicinal Products (OMP): Looking Back at the Past Decade

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
Orphan medicinal products’ access to the Bulgarian pharmaceutical market – challenges and obstacles
Maria Kamusheva ... Manoela Manova
Expert Opinion on Orphan Drugs | VOL. 6
Maria Kamusheva, et. al.Maria Kamusheva ... Manoela Manova
28 Dec 2017
Leveraging existing opportunities for improved Orphan Drug approval in the EU
Catarina Edfjäll
Orphanet Journal of Rare Diseases | VOL. 7
Catarina EdfjällCatarina Edfjäll
01 Jan 2012
Orphan Medicinal Products for the Treatment of Pancreatic Cancer: Lessons Learned From Two Decades of Orphan Designation.
Jorn Mulder ... Anna M G Pasmooij
Frontiers in Oncology | VOL. 11
Jorn Mulder, et. al.Jorn Mulder ... Anna M G Pasmooij
20 Dec 2021
Availability and Accessibility of Orphan Medicinal Products to Patients in Slovakia in the Years 2010-2019.
Tatiana Foltanova ... Alan Majernik
Frontiers in Pharmacology | VOL. 13
Tatiana Foltanova, et. al.Tatiana Foltanova ... Alan Majernik
26 Jan 2022
View more papers

More From: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research

Paper Title
Journal
Date
Author
The Functional Assessment of Cancer Therapy Eight Dimension (FACT-8D), a Multi-Attribute Utility Instrument Derived From the Cancer-Specific FACT-General (FACT-G) Quality of Life Questionnaire: Development and Australian Value Set
-
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research | VOL. -
--
21 Jun 2024
Market entry agreements for innovative pharmaceuticals subject to indication broadening: a case study for pembrolizumab in the Netherlands.
Renaud J S D Heine ... Carin A Uyl-De Groot
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research | VOL. -
Renaud J S D Heine, et. al.Renaud J S D Heine ... Carin A Uyl-De Groot
21 Jun 2024
MSR99 A Stacked Ensemble Approach for Building Composite Measure Models in Healthcare
P Shi ... S Zhang
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research | VOL. 27
P Shi, et. al.P Shi ... S Zhang
15 Jun 2024
EE98 A Theory-Based Framework to Incorporate Health Equity in Economic Assessments
S Subramanian ... S Hoover
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research | VOL. 27
S Subramanian, et. al.S Subramanian ... S Hoover
15 Jun 2024
View more papers